Genkore
Seoul, KR · 3 known investors
Genkore develops ultra-compact gene-editing technology to create therapeutic treatments for neurodegenerative diseases such as Huntington's and ALS. The company's gene scissors technology offers advantages in gene editing efficiency and delivery compared to existing approaches.
BiotechDeep TechMedical Devices
Founders & leadership
KY
Kim Yong-sam